CEACAM3—A Prim(at)e Invention for Opsonin-Independent Phagocytosis of Bacteria
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.03160
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2020
Authors
Publisher
Frontiers Media SA